Oral Sodium Phosphates (OSP) linked to kidney failure

FDA issues highest warning for prescription OSP products and additional warnings for over-the-counter OSPs

On December 11, 2008, the U.S. Food and Drug Administration (FDA) issued a Safety Alert calling for a black box warning to consumers and health care providers that a serious form of kidney injury, acute phosphate nephropathy, had been associated with the use of prescription OSP, namely Salix Pharmaceuticals’ and Osmo Prep. These products are generally prescribed prior to a or other medical procedure.

The FDA expressed equal concern of the use of over-the-counter (OTC) products such as Fleet Phospho-soda and Fleet Accu-Prep solutions for bowel clearing, though it emphasized that using the OTC products in low doses as a laxative did not pose a risk of acute kidney failure. However, the FDA plans to amend the labeling conditions for OTC OSP products to address this concern with bowel cleansing use.

In some cases, when used for bowel cleansing, these serious adverse events have occurred in patients without identifiable factors that would put them at risk for developing acute kidney injury.

In response to the FDA’s stern safety warning, C.B. Company Inc. announced a voluntary recall of its over-the-counter Fleet Phospho-soda and Phospho-soda EZ-Prep Bowel Cleansing System. On February 13, 2009, C.B. ceased the sale of its Prep Kit 1 product.

In a news release, Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research, said, “Though rare, these are serious adverse events associated with the use of oral sodium phosphates — both prescription and over-the-counter products.

“In some cases, these serious adverse events occurred in patients with no pre-existing health factors that would have put them at risk for developing kidney injury. We cannot rule out, however, that some of these patients were dehydrated prior to ingestion of OSP products or they did not drink sufficient fluids after ingesting OSP products.”

Free legal consultation

If you or a loved one has suffered from acute kidney failure or any other serious side effect as the result of taking either prescription or over-the-counter OSP products, you may be entitled to compensation.

Please contact our OSP lawyers today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost, no-obligation legal evaluation of your case.


Latest News

Too many colonoscopies performed on those at low risk for colon cancer

colonoscopy 150x150 Too many colonoscopies performed on those at low risk for colon cancerPeople considered “low risk” for colorectal cancer are having too many colonoscopies, and not enough patients considered “high risk” for the disease are having timely follow-up procedures, according to researchers with the University of Pittsburgh School of Medicine.

Read the rest of this entry »

People should be more proactive with their health

health checkup 150x150 People should be more proactive with their health“In the emergency room, I end up diagnosing a lot of cancer,” says Dr. Mylissa Graber, medical director of the emergency department at West Palm Beach’s Good Samaritan Medical Center. “People don’t go to the doctor, don’t follow up on getting their tests done, and show up when (diseases) are pretty advanced,” she said to the Palm Beach Post.

Read the rest of this entry »

Lawsuits citing kidney injury from OsmoPrep commence

judge gavelLawsuits began last month for four people who say the prescription bowel cleanser OsmoPrep caused them kidney damage that resulted in dialysis. OsmoPrep, made by Salix Pharmaceuticals, is a type of laxative called oral sodium phosphate, or OSP, used to cleanse the intestines prior to procedures such as . Salix Pharmaceuticals began marketing OsmoPrep in 2006. The drug generated more than $30 million in sales in 2008.

Read the rest of this entry »